NRAGE Peptide Inhibits Apoptosis in P19 Cells
Author Information
Author(s): Rochira Jennifer A., Matluk Nicholas N., Adams Tamara L., Karaczyn Aldona A., Oxburgh Leif, Hess Samuel T., Verdi Joseph M.
Primary Institution: University of Maine, Orono, Maine, United States of America
Hypothesis
The NRAGE repeat domain is pivotal in BMP MAPK signaling and apoptosis regulation.
Conclusion
The NRAGE peptide modeled after the NRAGE repeat domain can inhibit NF-κB activation and apoptosis in P19 cells.
Supporting Evidence
- NRAGE and XIAP proteins co-localize in the cytoplasm of P19 cells.
- FRET analysis indicates a direct interaction between NRAGE and XIAP.
- The NRAGE peptide reduces apoptosis in P19 cells exposed to retinoic acid and BMP-4.
- NRAGE peptide treatment leads to decreased levels of cleaved caspase-3 in P19 cells.
Takeaway
Scientists created a small piece of protein that can stop brain cells from dying when they are exposed to certain signals. This could help in treating diseases where too many brain cells die.
Methodology
The study used fluorescence resonance energy transfer (FRET) to analyze interactions between NRAGE and XIAP in P19 cells.
Limitations
The study primarily focused on a specific cell line (P19) and may not fully represent other cell types or in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website